Research Study Search Tool

Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?

Research & Clinical Trials > Study Search Tool > GENetic Education Risk Assessment and TEsting Study (GENERATE)

GENetic Education Risk Assessment and TEsting Study (GENERATE)

This study is open to:

You can participate if you:

  • Are 18 years of age or older
  • Have signed the informed consent
  • Have been informed about:
    • A first or second-degree relative with a diagnosis of pancreatic ductal adenocarcinoma (PDAC) and a germline mutation in APC, ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2, PMS2, STK11, or TP53,
    • An unaffected first or second-degree relative with a germline mutation in one of these genes who is a first or second-degree relative to a PDAC case (The germline and history of PDAC must both be on the maternal side or paternal side of your family)
  • Have a valid mailing address in the U.S. 
  • Have access to a healthcare provider and are willing to share genetic test results with that provider/the study team
  • Have never had genetic testing or counseling for cancer risk in the past
  • Are willing to undergo genetic testing (at no cost)
  • Are willing to complete a series of questionnaires for up to 15 months
This study is not open to:

Patients are excluded if they:

  • Have a known cancer susceptibility gene
  • Have received a bone marrow transplant, had a blood transfusion within the last 7 days, or have an active hematologic malignancy (i.e. leukemia or lymphoma)
  • Are unable to sign the informed consent because of a mental incompetency or psychiatric illness
  • Have a life expectancy of less than 1 year
  • Have had previous genetic testing or counseling regarding cancer risk
GENetic Education Risk Assessment and TEsting Study (GENERATE)

GENERATE identifier:


Study Contact Information

For any questions about the study, contact us by email or by phone: (617) 582-9444. 

About the Study

The goal of this research study is to increase the uptake of genetic testing among family members of pancreatic cancer patients who carry a genetic mutation.

This study involves education about genetic testing, undergoing genetic testing for cancer risk and completion of a series of 4 sets of questionnaires.

For more information, visit the study website

Type of Study

This is a two-arm, cluster randomized study.

  • This study has 2 arms, which means that families will be assigned into two different study groups.
  • This is a cluster randomized study, which means that families will be placed into one of the two groups by chance. Neither patients nor the research doctor will choose the group participants are placed in.

What the Study Entails

Participants who qualify for this study will:

  • Receive education about genetic testing
  • Fill out personal and family health history information
  • Undergo genetic testing (saliva sample) for 30 genes associated with inherited cancer risk
  • Complete a series of questionnaires regarding their cancer risk distress, knowledge of genetic testing, factors in decision making, degree of family communication about genetic test results, uptake of surveillance and experience 

Study Locations

There is no travel required for this study. People can participate from anywhere in the United States as long as they have Internet access. 

FORCE:Facing Our Risk of Cancer Empowered